Lupin Ltd. NSE: LUPIN | BSE: 500257

Mid-range Performer

Download real time

2055.60 9.00 (0.44%)

722.5K

NSE+BSE Volume

NSE 19 Sep, 2025 3:31 PM (IST)

US FDA Observation

Lupin receives Form 483 with six observations from the US FDA for its Nagpur injectable facility See details

Lupin Ltd. News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Lupin Ltd. authored by Geojit BNP Paribas and published by - Trendlyne research reports.
Item: Lupin Ltd.
Rating: 3
Author: Geojit BNP Paribas

Keep track of all breaking news and updates on Lupin Ltd. from all sources in a single place.

Load latest

Is Lupin Ltd. worth buying?

923 Votes:

Buy 72.81%

Sell 17.44%

Hold 9.75%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf